Moody’s said the two-notch downgrade reflects risks that the hospital will face as it transitions to a new IT system.
“While FMC will likely see improved operating results following a very weak fiscal 2018, recovery will be slower than anticipated, in part hampered by weak volume trends attributed to both the IT project as well as the loss of a key physician for a period of time during 2019,” Moody’s said.
The 222-bed hospital has seen liquidity metrics decline due to IT billing and collection issues, but management expects these metrics to improve as collection matters are resolved.
The negative outlook also reflects Moody’s belief that the hospital will face challenges as it completes the transition to its new clinical and billing IT system.
“This will contribute to protracted weakness in margins and cash metrics and, along with rising debt levels and small size, will result in higher uncertainty,” Moody’s said.
More articles on healthcare finance:
Private equity pushes into healthcare: 9 latest deals
10 hospitals seeking CFOs
Hospital operator loses 2 top execs as stock faces delisting
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
